abstraet
batteri
vitro
vivo
test
conduct
vapour
bacteri
gene
mutat
assay
escherichia
coli
salmonella
typhimurium
neg
tester
strain
vitro
chromosom
aberr
assay
posit
cho
cell
neg
human
lymphocyt
moreov
neg
vivo
mous
micronucleu
inhal
assay
basi
data
previous
report
genotox
test
consid
nongenotox
group
male
femal
spraguedawley
rat
expos
inhal
hrday
dayswk
vapour
wk
target
concentr
control
ppm
increas
exposur
exposurerel
effect
toxicolog
signific
note
respect
surviv
clinic
sign
ophthalmoscopi
haematolog
clinic
chemistri
urinalysi
organ
weight
analysi
reduc
food
intak
bodi
weight
gain
note
sex
ppm
group
first
wk
thereaft
bodi
weight
gain
group
similar
although
intergroup
differ
bodi
weight
remain
evid
reduc
food
intak
persist
sex
wk
femal
second
year
exposur
treatmentrel
effect
macroscop
patholog
confin
increas
incid
testicular
mass
alter
appear
microscop
patholog
examin
confirm
test
target
organ
find
increas
incid
benign
interstiti
cell
tumour
hyperplasia
ppm
noobservableadverseeffect
level
noael
ppm
testicular
chang
high
exposur
level
consid
due
chang
senil
hormon
imbal
geriatr
rat
littl
signific
assess
human
health
effect
l
ldichloro
ifluoroethan
ca
colourless
volatil
liquid
boil
point
vapour
pressur
faint
ether
odour
develop
primarili
replac
cfc
produc
rigid
polyurethan
polyisocyanur
phenol
insul
foam
major
use
foam
includ
insul
roof
commerci
build
either
foam
board
spray
directli
onto
roof
insul
foam
board
resid
residenti
caviti
insul
foaminplac
foam
fill
surround
walkin
domest
refriger
smaller
potenti
applic
solvent
replac
cfc
remov
solder
flux
print
circuit
board
precis
clean
intric
part
combin
surfact
remov
trace
water
intric
part
program
altern
fluorocarbon
toxic
test
paft
worldwid
multin
consortium
chemic
manufactur
undertook
extens
program
toxic
test
togeth
program
potenti
cfc
replac
materi
potenti
exposur
manufactur
use
test
program
includ
assess
toxic
ecotox
well
oncogen
genotox
developmentalreproduct
toxic
endpoint
result
present
confin
genotox
oncogen
test
studi
aspect
program
report
separ
european
chemic
industri
ecolog
toxicolog
centr
ecetoc
review
much
avail
inform
previou
acut
toxic
studi
practic
nontox
oral
dermal
inhal
rout
acut
valu
greater
mgkg
rat
greater
mgkg
rabbit
ppm
rat
hr
exposur
respect
ecetoc
subchron
inhal
toxic
studi
rat
exposur
hrday
dayswk
wk
indic
noobservableadverseeffect
level
noael
ppm
minor
reduct
bodi
weight
gain
studi
relat
slightli
higher
exposur
chamber
temperatur
compar
control
chamber
owe
use
heat
volatil
gener
ecetoc
noael
reinforc
similar
noael
subsequ
studi
hino
et
al
metabol
studi
indic
absorpt
occur
indic
rico
metabol
ecetoc
harri
ander
confirm
poorli
metabol
rat
major
metabolit
elimin
urin
glucuronid
conjug
result
avail
genet
toxic
summar
previou
review
paper
ecetoc
intern
programm
chemic
safeti
ipc
howev
view
import
genotox
data
assess
carcinogen
hazard
report
recent
inform
addit
detail
genotox
studi
conduct
ca
volatil
liquid
suppli
inhal
studi
pressur
contain
elf
atochem
na
elf
atochem
sa
minimum
puriti
vv
puriti
batch
test
materi
determin
duplic
ga
chromatographymass
spectroscopi
gcm
analysi
two
differ
laboratori
smaller
sampl
meet
puriti
criteria
suppli
elf
atochem
na
elf
atochem
sa
ei
dupont
de
nemour
co
inc
genotox
studi
test
systemstest
condit
intern
accept
protocol
good
laboratori
practic
rule
follow
base
organis
econom
cooper
develop
oecd
unit
state
environment
protect
agenc
us
epa
japanes
ministri
intern
trade
industri
miti
guidelin
studi
conduct
use
vapour
phase
apparatu
use
expos
mammalian
cell
cultur
describ
recent
present
hodsonwalk
et
al
bacteri
assay
perform
close
stainlesssteel
vapour
exposur
vessel
vitro
studi
conduct
without
metabol
activ
liver
homogen
mix
prepar
aroclor
spragu
dawley
rat
ame
test
examin
mutageni
activ
five
histidinedepend
auxotroph
salmonella
typhimurium
strain
tryptophandepend
auxotroph
escherichia
coli
strain
uvra
use
procedur
agar
plate
seed
tester
strain
expos
test
materi
vapour
phase
test
conduct
two
separ
occas
test
concentr
vv
first
studi
vv
second
studi
exposur
level
select
follow
preliminari
toxic
test
follow
exposur
incub
plate
remov
chamber
incub
hr
actual
exposur
concentr
analys
sampl
remov
chamber
hr
hromomm
aberr
assay
chines
hamster
marv
tcho
ki
cell
effect
chromosom
structur
assess
cultur
cell
maintain
hanr
nutrient
medium
supplement
foetal
calf
serum
antibiot
cell
grown
monolay
intern
surtac
steril
screwcap
glass
bottl
place
roller
full
rotat
everi
rain
ad
cultur
vessel
achiev
desir
test
atmospher
concentr
vv
base
preliminari
assess
toxic
cell
expos
test
materi
hr
hr
twithout
mitomycin
c
cyclophosphamid
use
posit
control
mitot
indic
calcul
observ
metaphas
per
cell
chromosom
aberr
express
cell
one
aberr
cell
score
chromosom
aberr
assay
human
effect
chromosom
structur
investig
phytohaemagglutininstimul
human
lymphocyt
obtain
singl
healthi
nonsmok
human
male
current
take
medic
cultur
lymphocyt
maintain
hr
transfer
steril
screwcap
glass
bottl
incub
vapour
concentr
vv
without
bottl
place
roller
full
rotat
everi
min
cultur
without
incub
hr
respect
cyclophosphamid
chlorambucil
use
posit
control
metaphas
cell
spread
two
slide
cultur
score
chromosom
aberr
mous
bone
marrow
micronucleu
assay
group
cdi
mice
per
sex
expos
whole
bodi
hr
vapour
concentr
ppm
vv
glass
cylind
chamber
test
concentr
select
initi
rangefind
studi
ppm
exposur
induc
mortal
within
induc
overt
narcot
effect
consequ
select
main
studi
highest
concentr
would
caus
excess
toxic
bone
marrow
smear
prepar
femur
five
mice
per
sex
per
level
kill
hr
exposur
group
mice
receiv
cyclophosphamid
mg
ip
serv
posit
control
polychromat
erythrocyt
pce
score
presenc
micronuclei
micronuclei
normochromat
erythrocyt
pne
score
pce
pne
ratio
calcul
test
atmospher
analys
atmospher
sampl
test
concentr
remov
vessel
chamber
analys
ga
chromatographi
actual
concentr
typic
close
intend
concentr
albino
rat
spraguedawley
strain
crl
cd
sd
br
obtain
charl
river
breed
laboratori
portag
michigan
usa
anim
approxim
wk
age
receipt
hous
group
four
rat
sex
stainlesssteel
mesh
cage
plastic
tray
absorb
liner
place
cage
collect
excreta
blood
sampl
obtain
sentinel
group
male
femal
prior
studi
initi
determin
health
statu
coloni
haematolog
virolog
elisa
mycoplasma
pulmoni
rat
corona
virussialodacryoaden
viru
pneumonia
viru
mice
sendai
viru
kilham
rat
viru
toolan
viru
examin
undertaken
anim
subject
detail
autopsi
examin
anim
ad
lib
access
food
sd
certifi
rat
mous
mainten
diet
tap
water
psig
pound
per
sq
gaug
pressur
psig
pascal
tgcfid
ga
chromatographi
flame
ioniz
detector
toxic
nonexposur
period
analysi
diet
water
indic
contamin
present
could
affect
outcom
integr
studi
room
temperatur
humid
control
target
rang
respect
photoperiod
also
maintain
automat
rat
alloc
four
group
contain
rat
sex
stratifi
pseudorandom
process
base
bodi
weight
group
mean
bodi
weight
group
random
g
male
g
femal
addit
rat
sex
alloc
sentinel
group
design
health
screen
elisa
includ
pretest
interv
throughout
studi
durat
three
cage
sex
alloc
two
hold
room
use
studi
expos
test
materi
treat
rat
expos
use
wholebodi
system
vapour
hr
day
dayswk
rat
individu
hous
exposur
rotat
anim
within
chamber
period
elimin
posit
bia
exposur
level
control
ppm
high
exposur
level
increas
ppm
wk
exposur
light
minim
toxic
note
point
studi
exposur
continu
wk
surviv
rat
randomli
kill
exposur
chamber
construct
stainlesssteel
stainlesssteel
frame
glass
panel
door
oper
slight
neg
pressur
mmhg
ambient
atmospher
pressur
airflow
approxim
litresmin
inlet
air
vapourcontain
air
stream
enter
top
pyramid
section
chamber
dispers
devic
vapour
produc
meter
liquid
allglass
concentr
jet
atom
surround
integr
waterjacket
heat
jacket
continu
suppli
hot
water
thermostirr
pump
vapour
produc
evapor
liquid
swept
chamber
clean
dri
compress
air
high
exposur
level
air
suppli
heat
passag
copper
coil
immers
waterbath
constant
flow
liquid
atom
achiev
use
nitrogen
top
pressur
three
reservoir
psig
ppm
level
liquid
reservoir
place
load
cell
regist
weight
loss
exposur
inlin
filtrat
system
ensur
clean
particlefre
suppli
bulk
drum
chamber
airflow
reservoir
weight
temperatur
humid
chamber
concentr
gcfid
monitor
everi
min
use
central
computer
monitor
record
system
end
exposur
period
data
summar
group
basi
chamber
atmospher
sampl
withdrawn
four
port
chamber
wall
determin
chamber
concentr
atmospher
homogen
cage
check
least
twice
daili
dead
moribund
anim
thorough
extern
examin
anim
perform
week
individu
bodi
weight
record
initi
exposur
weekli
wk
everi
thereaft
food
intak
cage
basi
record
weekli
throughout
studi
eye
rat
use
studi
examin
indirect
ophthalmoscop
exposur
initi
wk
exposur
five
rat
ocular
abnorm
preexposur
examin
replac
exposur
commenc
blood
urin
sampl
collect
wk
rat
sex
haematolog
biochemistri
urinalysi
group
sampl
overnight
period
food
depriv
anim
allow
approxim
hr
access
water
follow
exposur
initi
urin
collect
blood
sampl
preserv
sodium
citrat
clot
assay
edta
haematolog
assay
lithium
heparin
clinic
chemistri
assay
haematolog
assay
perform
use
ortho
hematolog
analyz
includ
haematocrit
haemoglobin
leucocyt
erythrocyt
platelet
count
cell
morpholog
thrombotest
blood
smear
stain
modifi
wright
stain
use
leucocyt
differenti
count
base
count
leucocyt
mean
corpuscular
haemoglobin
mean
corpuscular
haemoglobin
concentr
mean
corpuscular
volum
calcul
measur
erythrocyt
indic
follow
centrifug
g
min
plasma
sampl
analys
use
roch
coba
centrifug
analyz
glucos
alanin
aminotransferas
aspart
aminotransferas
lactat
dehydrogenas
transpeptidas
creatin
phosphokinas
triglycerid
total
phospholipid
plasma
sampl
also
analys
use
hitachi
clinic
chemistri
analyz
total
protein
albumin
globulin
albuminglobulin
ratio
calcul
urea
nitrogen
alkalin
phosphatas
total
bilirubin
creatinin
sodium
potassium
calcium
inorgan
phosphat
chlorid
cholesterol
sampl
blood
rat
kill
wk
treatment
remov
prior
autopsi
allow
clot
analys
serum
fluorid
concentr
urinalysi
measur
compris
volum
colour
appear
ph
specif
graviti
osmol
protein
fluorid
qualit
test
glucos
keton
bile
pigment
urobilinogen
haem
pigment
follow
centrifug
urinari
sediment
examin
microscop
epitheli
cell
polymorphonuclear
leucocyt
mononuclear
leucocyt
erythrocyt
organ
renal
tubul
cast
abnorm
constitu
wk
exposur
predesign
anim
sex
group
use
interim
autopsi
examin
one
male
control
low
high
exposur
level
group
one
femal
control
low
exposur
group
surviv
interim
kill
interv
anim
replac
rat
surviv
termin
schedul
interim
kill
either
found
dead
kill
extremi
subject
detail
autopsi
examin
follow
exsanguin
pentobarbiton
anaesthesia
unless
found
dead
organ
weight
record
brain
pituitari
thyroid
heart
lung
liver
spleen
kidney
adren
gonad
approxim
tissu
sampl
preserv
neutral
buffer
formalin
except
eye
preserv
davidson
fluid
lung
infus
trachea
prior
immers
fix
lightmicroscop
examin
follow
stain
haematoxylin
eosin
examin
tissu
confin
anim
control
high
exposur
group
nasal
turbin
lung
liver
kidney
test
macroscop
abnorm
low
intermedi
exposur
level
group
tissu
deced
group
also
examin
testicular
patholog
find
submit
independ
peer
review
size
criterion
use
distinguish
leydig
cell
adenoma
focal
hyperplasia
foci
size
larger
crosssect
one
seminifer
tubul
classifi
adenoma
statist
analysi
statist
techniqu
appli
measur
variabl
bartlett
test
use
test
homogen
varianc
varianc
significantli
differ
level
logarithm
transform
appli
signific
heterogen
detect
oneway
analysi
varianc
follow
student
ttest
william
test
doserel
respons
perform
nonparametr
evalu
kruskalw
analysi
rank
nonparametr
equival
test
ttest
william
test
use
two
test
conduct
assess
induct
point
mutat
prokaryot
organ
typhimurium
e
coli
may
typhimurium
may
respect
gave
neg
result
tester
strain
without
microsom
metabol
activ
test
concentr
test
evalu
potenti
caus
chromosom
damag
gave
conflict
result
test
cho
ki
cell
increas
chromosom
aberr
incid
without
metabol
activ
hodsonwalk
increas
aberr
cell
frequenc
neg
control
valu
nonactiv
cultur
expos
found
statist
signific
exclud
includ
gap
p
p
respect
presenc
mix
statist
signific
increas
aberr
cell
frequenc
seen
treat
cultur
gap
includ
cultur
expos
exclud
gap
p
case
follow
hr
exposur
statist
signific
increas
frequenc
aberr
cell
seen
concentr
howev
follow
hr
exposur
statist
signific
increas
aberr
cell
frequenc
observ
level
whether
gap
includ
exclud
human
lymphocyt
assay
inact
hodsonwalk
induc
statist
signific
increas
frequenc
aberr
cell
neg
control
valu
concentr
test
p
either
absenc
mix
concentr
presenc
mix
concentr
whether
gaptyp
aberr
includ
exclud
analysi
also
inact
vivo
mous
micronucleu
assay
vlacho
statist
signific
increas
frequenc
micronucl
cell
seen
mice
time
sampl
test
concentr
examin
includ
ppm
pce
pne
ratio
significantli
chang
lethargi
tremor
bodi
weight
loss
observ
anim
expos
ppm
mean
nomin
chamber
concentr
standard
deviat
parenthes
calcul
weight
loss
reservoir
exposur
divid
total
chamber
air
flow
exposur
period
ppm
control
ppm
group
respect
actual
chamber
concentr
ppm
respect
chamber
airflow
vari
litresminut
temperatur
rang
higher
temperatur
gener
record
high
exposur
level
chamber
owe
use
preheat
compress
air
facilit
vapor
high
concentr
need
group
intergroup
chamber
temperatur
differ
consid
affect
valid
studi
rel
humid
rang
clinic
sign
note
group
associ
exposur
overal
surviv
treat
group
similar
better
control
group
approx
male
femal
surviv
male
treat
group
higher
control
group
indic
presumpt
caus
death
relat
exposur
exposur
caus
slight
statist
signific
p
reduct
food
intak
bodi
weight
gain
fig
first
wk
food
intak
also
reduc
ppm
wk
effect
bodi
weight
gain
particularli
notic
male
subsequ
rate
bodi
weight
gain
similar
treat
control
group
despit
increas
high
exposur
level
ppm
wk
food
intak
femal
high
exposur
group
significantli
reduc
p
compar
control
intergroup
differ
type
incid
ocular
abnorm
detect
ophthalmoscop
examin
haematolog
indic
clinic
chemistri
analys
indic
exposurerel
effect
although
occasion
increas
serum
triglycerid
concentr
chang
triglycerid
obviou
first
month
exposur
period
high
exposur
group
level
increas
control
valu
p
p
signific
femal
week
respect
p
signific
signific
male
wk
respect
although
rel
small
alway
statist
signific
chang
may
relat
exposur
qualit
quantit
urinalysi
data
indic
effect
treatment
occasion
statist
signific
differ
urinari
fluorid
concentr
note
expos
group
although
neither
consist
suffici
magnitud
indic
associ
treatment
organ
weight
analysi
reveal
intergroup
differ
apart
small
increas
kidney
weight
femal
wk
slightli
decreas
thyroid
weight
femal
ppm
slightli
increas
adren
weight
femal
ppm
wk
absenc
dose
respons
similar
effect
male
corrobor
microscop
patholog
find
differ
consid
toxicolog
signific
intergroup
differ
respect
macroscop
patholog
find
wk
termin
treatmentrel
macroscop
chang
except
testicular
mass
testicular
abnorm
small
blue
flaccid
white
subtun
striae
slightli
excess
control
group
male
tabl
microscop
patholog
examin
show
treatmentrel
lesion
femal
male
except
test
effect
apart
small
increas
number
vacuol
sinusoid
histiocyt
cervic
lymph
node
ppm
microscop
patholog
examin
confirm
test
target
organ
find
increas
testicular
hyperplasia
benign
testicular
interstiti
cell
tumour
incid
margin
increas
incid
seminifer
tubul
atrophi
differ
regard
incid
occurr
macroscop
find
relat
geriatr
earli
neoplast
chang
consid
unrel
treatment
incid
benign
testicular
interstiti
cell
leydig
cell
adenoma
increas
ppm
increas
incid
outsid
histor
control
rang
strain
rat
test
laboratori
tumour
found
predominantli
rat
kill
termin
statist
analysi
use
intern
agenc
research
cancer
iarc
timetotumour
method
iarc
show
pairwis
comparison
control
group
group
statist
signific
p
p
respect
trend
analysi
also
statist
signific
p
evid
treatmentinduc
neoplasia
respiratori
tract
polypoid
adenoma
nasal
turbin
found
male
rat
ppm
pulmonari
adenoma
singl
male
rat
ppm
pulmonari
adenocarcinoma
male
rat
ppm
ii
tabl
type
incid
neoplasm
within
rang
normal
expect
reflect
effect
treatment
tabl
increas
incid
moder
interstiti
hyperplasia
tabl
note
test
rat
ppm
although
differ
control
attain
statist
signific
similar
increas
incid
ppm
mark
attain
statist
signific
p
effect
seen
ppm
incid
testicular
seminifer
tubul
moder
mark
degre
atrophi
margin
increas
ppm
group
compar
control
differ
statist
signific
tabl
find
correl
increas
incid
smallblueflaccidwhit
striae
note
autopsi
testicular
atrophi
seen
either
ppm
genet
toxic
respect
mutat
clastogeni
endpoint
evalu
test
program
appear
clearli
nonmutagen
ame
bacteri
test
two
occas
ecetoc
ipc
report
result
assay
conduct
prior
standard
sampl
puriti
impur
content
test
consortium
one
neg
ame
test
find
report
two
posit
result
without
mix
typhimurium
strain
also
note
known
whether
sampl
use
ecetocreport
studi
met
analyt
criteria
establish
major
test
program
potenti
abnorm
impur
high
level
expect
contamin
may
explain
isol
posit
result
note
earlier
test
result
ecetoc
ipc
also
report
result
hypoxanthin
phosphoribosyitransferas
hprt
assay
chines
hamster
cell
expos
vapour
increas
mutat
frequenc
hprt
gene
locu
presenc
absenc
furthermor
neg
result
also
report
dna
repair
assay
e
coli
expos
liquid
phase
without
neg
result
hprt
cell
dna
repair
assay
reinforc
overal
conclus
mutagen
test
chromosom
aberr
yield
somewhat
conflict
result
paft
vitro
chromosom
aberr
assay
found
posit
cho
cell
neg
human
lymphocyt
furthermor
materi
found
neg
vivo
mous
bone
marrow
micronucleu
assay
ecetoc
ipc
report
two
addit
chromosom
aberr
assay
use
cho
cell
one
studi
gave
posit
result
without
vapour
wherea
equivoc
liquid
incorpor
directli
cultur
medium
second
vivo
mous
micronucleu
test
also
report
neg
ecetoc
micronucleu
test
report
ecetoc
well
abovereport
micronucleu
test
conduct
subleth
concentr
high
enough
induc
overt
toxic
sign
mice
includ
nervou
system
depress
effect
indic
toxic
bone
marrow
evidenc
alter
pce
pcn
ratio
howev
like
freeli
distribut
blood
tissu
includ
bone
marrow
small
twocarbon
molecul
easili
diffus
blood
tissu
compart
demonstr
rapidonset
anaesthet
properti
indic
cross
bloodbrain
barrier
basi
weight
evid
ecetoc
conclud
demonstr
toxicolog
signific
mutagen
activ
american
industri
hygien
associ
workplac
environment
exposur
level
weel
committe
aiha
state
mutagen
statist
signific
increas
lateonset
benign
testicular
interstiti
tumour
ppm
must
analys
context
absenc
genotox
potenti
defin
vitro
vivo
mutagen
assay
nongenotox
epigenet
mechan
need
consid
explain
increas
incid
tumour
nongermin
cell
testicular
tumour
human
extrem
rare
chomett
et
al
damjanov
et
al
mostofi
incid
leydig
cell
tumour
studi
maxim
total
number
testicular
tumour
epidemiolog
studi
us
damjanov
et
al
devesa
silverman
franc
haillot
et
al
ireland
thornhil
et
al
yield
combin
incid
leydig
cell
tumour
per
million
men
predomin
testicular
tumour
type
human
germin
cell
tumour
seminoma
teratoma
teratocarcinoma
rat
leydig
cell
adenoma
ageassoci
benign
tumour
uncommon
human
natur
incid
vari
accord
strain
pronounc
fischer
strain
often
reach
anim
bir
extens
evid
induct
leydig
cell
tumour
rodent
occur
epigenet
mechan
involv
excess
gonadotroph
stimul
review
bjr
author
conclud
leydig
cell
tumour
commonli
occur
rat
result
increas
pituitari
lutein
hormon
lh
secret
increas
testicular
lhhuman
chorion
gonadotrophin
hcg
receptor
impair
androgen
biosynthesi
action
wide
varieti
materi
includ
lactos
lactitol
procedur
shown
induc
format
leydig
cell
tumour
bir
report
bjr
robert
et
al
increas
incid
interstiti
cell
tumour
follow
ligat
testicular
blood
vessel
intrasplen
graft
testi
gonadotrophin
inject
radiat
administr
wide
varieti
unrel
drug
cimetidin
hydralazin
gemfibrizol
carbamazepin
vidarabin
mesulargin
isradipin
metronidazol
also
result
elev
interstiti
cell
tumour
mass
griffith
senil
per
se
also
signific
contributor
appear
leydig
cell
tumour
rat
exampl
fischer
rat
incid
interstiti
celt
tumour
end
life
case
mesulargin
prentic
et
al
isradipin
robert
et
al
associ
increas
lh
reduc
prolactin
induct
leydig
cell
tumour
demonstr
evid
human
associ
occurr
leydig
cell
tumour
hormon
imbal
case
control
studi
human
shown
relationship
prenat
oestrogen
treatment
henderson
et
al
leari
et
al
loughlin
et
al
schottenfeld
et
al
cadmium
exposur
armstrong
kazantzi
elind
et
al
chronic
administ
drug
bir
induc
leydig
cell
tumour
rat
thu
develop
leydig
cell
tumour
rat
appear
speciesspecif
phenomenon
littl
relev
human
onset
time
hormon
perturb
rat
mesulargin
approxim
wk
isradipin
wk
although
time
appear
tumour
approx
yr
control
rat
leydig
cell
tumour
usual
occur
late
life
month
old
age
appear
prerequisit
develop
tumour
rodent
late
onset
also
characterist
chemic
induc
leydig
cell
tumour
case
tumour
benign
evid
progress
malign
fact
tumour
rodent
consid
progress
malign
j
f
hardisti
person
commun
chemic
unreact
poorli
metabol
vivo
accumul
tissu
metabol
minim
approxim
materi
dechlorin
vitro
rat
hepat
microsom
incub
van
dyke
increas
urinari
fluorid
detect
rat
inhal
studi
use
fischer
rat
present
studi
spraguedawley
rat
vivo
inhal
exposur
spraguedawley
rat
screen
test
fail
demonstr
metabol
use
closedloop
exposur
system
continu
monitor
exposur
atmospher
infrar
analysi
ecetoc
method
estim
sensit
enough
detect
metabol
materi
exposur
male
fischer
rat
hr
mgm
subsequ
collect
urin
expir
air
demonstr
presenc
singl
fluorin
metabolit
glucuronid
concentr
analysi
cytosol
microsom
fraction
liver
expos
rat
use
nuclear
magnet
reson
technolog
detect
coval
bind
fluorin
speci
harri
ander
limit
metabol
retent
would
predict
minim
potenti
biolog
activ
reactiv
metabol
pathway
basic
characterist
rat
spontan
interstiti
cell
tumour
present
studi
alter
exposur
tumour
occur
predominantli
age
anim
b
benign
natur
c
lifethreaten
consequ
pituitarytesticular
axi
disrupt
shown
link
known
exogen
caus
increas
incid
leydig
cell
tumour
rat
bir
cook
et
al
rao
reddi
consid
like
explan
effect
estim
exposur
concentr
manufactur
insul
foam
indic
level
significantli
current
gener
accept
exposur
guidelin
aiha
model
residenti
exposur
result
slow
releas
insul
foam
use
home
construct
indic
timeweight
averag
concentr
first
year
occup
like
maxim
ppb
first
yr
occup
approxim
ppb
environ
potenti
exposur
estim
use
worstcas
scenario
exposur
time
concentr
strong
suggest
underli
hormon
mechan
absenc
genotox
potenti
conjunct
late
onset
leydig
cell
tumour
rat
extrem
rariti
tumour
human
indic
threshold
exist
thu
risk
character
base
noael
tumour
ppm
although
noael
system
toxic
ppm
twostag
linear
carcinogenesi
model
appropri
epigenet
mechan
tumorigenesi
overal
assess
toxicolog
genotox
data
indic
low
order
toxic
lack
genotox
potenti
chronic
noael
sever
order
magnitud
higher
probabl
human
exposur
basi
minim
human
exposur
potenti
compar
high
exposur
receiv
laboratori
anim
lack
relev
human
risk
assess
interstiti
cell
tumour
expos
rat
conclud
like
pose
risk
human
health
